Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.

Hofmann, C A

Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. [electronic resource] - Endocrinology Feb 1992 - 735-40 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

0013-7227

10.1210/endo.130.2.1733721 doi


Animals
Crosses, Genetic
Diabetes Mellitus--genetics
Diabetes Mellitus, Experimental--genetics
Female
Hypoglycemic Agents--pharmacology
Insulin--blood
Insulin Resistance
Kinetics
Liver--drug effects
Male
Mice
Mice, Inbred C57BL
Mice, Obese
Monosaccharide Transport Proteins--genetics
Obesity
Phosphoenolpyruvate Carboxykinase (GTP)--genetics
Pioglitazone
RNA, Messenger--genetics
Thiazoles--pharmacology
Thiazolidinediones